Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C

Overview of attention for article published in Investigational New Drugs, February 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS, 13 Feb 2017

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recur https://t.co/yy7R2iGIjQ #hvh…